Antleron
Ambachtenlaan 1
3001 Leuven
BE
Antleron
Foundation date
21/11/2014
Sector
#Biotechnology / R&D ServicesTherapeutic areas
- #Cardiovascular
- #Digestive system
- #Diseases of the blood and blood-forming organs - immune disorders
- #Injury - poisoning and certain other consequences of external causes
- #Musculoskeletal system and connective tissue
- #Skin and subcutaneous tissue
- #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified
We are Antleron, a nimble team that will revolutionise medicine by leading the development of next generation advanced therapies and medical devices. By merging the potential of cells, biomaterials, biologics, 3D printing and bioreactors we will accelerate the engineering of medicinal products, devices and processes that will change health care and result in a better life for all. The Antleron business philosophy is to create sustainable ventures through risk & reward sharing partnerships.
Upcoming events
All events-
1804 '24
Anglonordic Life Science Conference 2024
Event by: BioPartner -
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
2304 '24
BioTrinity 2024
Event by: OBN
Latest news
More news-
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
Wednesday March 27th 2024
Read more
-
InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline
Tuesday March 26th 2024
Read more
-
Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy
Monday March 25th 2024
Read more
Jobs
More jobs-
28/03/24
Flemish Brabant
Post-doc position – Structural Bioinformatics of protein interactions
Permanent
VIB -
-
More info?
Ellen Telleir
Communication Coordinator